nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—atherosclerosis	0.146	1	CbGaD
Levothyroxine—SLCO1B3—Rosuvastatin—atherosclerosis	0.0739	0.11	CbGbCtD
Levothyroxine—SLCO1B3—Pravastatin—atherosclerosis	0.0672	0.1	CbGbCtD
Levothyroxine—SLCO1A2—Rosuvastatin—atherosclerosis	0.0456	0.0679	CbGbCtD
Levothyroxine—SLCO1B1—Rosuvastatin—atherosclerosis	0.043	0.0641	CbGbCtD
Levothyroxine—SLCO1B1—Ezetimibe—atherosclerosis	0.043	0.0641	CbGbCtD
Levothyroxine—SLCO1A2—Simvastatin—atherosclerosis	0.0424	0.0632	CbGbCtD
Levothyroxine—SLCO1A2—Pravastatin—atherosclerosis	0.0415	0.0618	CbGbCtD
Levothyroxine—SLCO1A2—Lovastatin—atherosclerosis	0.0415	0.0618	CbGbCtD
Levothyroxine—SLCO1B1—Simvastatin—atherosclerosis	0.04	0.0596	CbGbCtD
Levothyroxine—SLCO1B1—Lovastatin—atherosclerosis	0.0391	0.0583	CbGbCtD
Levothyroxine—SLCO1B1—Pravastatin—atherosclerosis	0.0391	0.0583	CbGbCtD
Levothyroxine—ALB—Rosuvastatin—atherosclerosis	0.0236	0.0351	CbGbCtD
Levothyroxine—CYP2C8—Simvastatin—atherosclerosis	0.0169	0.0252	CbGbCtD
Levothyroxine—CYP2C8—Lovastatin—atherosclerosis	0.0166	0.0247	CbGbCtD
Levothyroxine—CYP2C8—Pravastatin—atherosclerosis	0.0166	0.0247	CbGbCtD
Levothyroxine—ABCB1—Ezetimibe—atherosclerosis	0.0123	0.0184	CbGbCtD
Levothyroxine—ABCB1—Simvastatin—atherosclerosis	0.0115	0.0171	CbGbCtD
Levothyroxine—ABCB1—Lovastatin—atherosclerosis	0.0112	0.0167	CbGbCtD
Levothyroxine—ABCB1—Pravastatin—atherosclerosis	0.0112	0.0167	CbGbCtD
Levothyroxine—CYP3A4—Ezetimibe—atherosclerosis	0.00738	0.011	CbGbCtD
Levothyroxine—CYP3A4—Rosuvastatin—atherosclerosis	0.00738	0.011	CbGbCtD
Levothyroxine—CYP3A4—Simvastatin—atherosclerosis	0.00687	0.0102	CbGbCtD
Levothyroxine—CYP3A4—Lovastatin—atherosclerosis	0.00672	0.01	CbGbCtD
Levothyroxine—CYP3A4—Pravastatin—atherosclerosis	0.00672	0.01	CbGbCtD
Levothyroxine—Muscular weakness—Rosuvastatin—atherosclerosis	0.00102	0.0151	CcSEcCtD
Levothyroxine—Muscular weakness—Ezetimibe—atherosclerosis	0.000849	0.0125	CcSEcCtD
Levothyroxine—THRA—connective tissue—atherosclerosis	0.000817	0.066	CbGeAlD
Levothyroxine—Affect lability—Pravastatin—atherosclerosis	0.000817	0.012	CcSEcCtD
Levothyroxine—Muscular weakness—Simvastatin—atherosclerosis	0.00081	0.0119	CcSEcCtD
Levothyroxine—Mood swings—Pravastatin—atherosclerosis	0.000786	0.0116	CcSEcCtD
Levothyroxine—Muscular weakness—Niacin—atherosclerosis	0.000744	0.011	CcSEcCtD
Levothyroxine—Muscular weakness—Pravastatin—atherosclerosis	0.000732	0.0108	CcSEcCtD
Levothyroxine—Dysphagia—Niacin—atherosclerosis	0.000729	0.0107	CcSEcCtD
Levothyroxine—Arrhythmia—Rosuvastatin—atherosclerosis	0.000716	0.0106	CcSEcCtD
Levothyroxine—SERPINA7—liver—atherosclerosis	0.000712	0.0575	CbGeAlD
Levothyroxine—THRA—cardiovascular system—atherosclerosis	0.000711	0.0574	CbGeAlD
Levothyroxine—Angina pectoris—Niacin—atherosclerosis	0.00071	0.0105	CcSEcCtD
Levothyroxine—Angina pectoris—Pravastatin—atherosclerosis	0.000699	0.0103	CcSEcCtD
Levothyroxine—Sweating increased—Pravastatin—atherosclerosis	0.000699	0.0103	CcSEcCtD
Levothyroxine—Weight decreased—Pravastatin—atherosclerosis	0.000649	0.00957	CcSEcCtD
Levothyroxine—Angioedema—Rosuvastatin—atherosclerosis	0.000637	0.0094	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000631	0.0093	CcSEcCtD
Levothyroxine—Flushing—Lovastatin—atherosclerosis	0.00063	0.00929	CcSEcCtD
Levothyroxine—THRB—adipose tissue—atherosclerosis	0.000627	0.0507	CbGeAlD
Levothyroxine—THRA—adipose tissue—atherosclerosis	0.000627	0.0507	CbGeAlD
Levothyroxine—Myocardial infarction—Pravastatin—atherosclerosis	0.000627	0.00924	CcSEcCtD
Levothyroxine—SLC7A5—connective tissue—atherosclerosis	0.000624	0.0504	CbGeAlD
Levothyroxine—Sweating—Niacin—atherosclerosis	0.000623	0.00918	CcSEcCtD
Levothyroxine—Flushing—Ezetimibe—atherosclerosis	0.000618	0.00911	CcSEcCtD
Levothyroxine—TTR—connective tissue—atherosclerosis	0.000608	0.0491	CbGeAlD
Levothyroxine—Alopecia—Lovastatin—atherosclerosis	0.0006	0.00885	CcSEcCtD
Levothyroxine—Arthralgia—Rosuvastatin—atherosclerosis	0.000594	0.00875	CcSEcCtD
Levothyroxine—Flushing—Simvastatin—atherosclerosis	0.00059	0.00869	CcSEcCtD
Levothyroxine—Alopecia—Ezetimibe—atherosclerosis	0.000589	0.00868	CcSEcCtD
Levothyroxine—Confusional state—Rosuvastatin—atherosclerosis	0.000574	0.00846	CcSEcCtD
Levothyroxine—SLC16A2—adipose tissue—atherosclerosis	0.000568	0.0459	CbGeAlD
Levothyroxine—Alopecia—Simvastatin—atherosclerosis	0.000561	0.00827	CcSEcCtD
Levothyroxine—Tremor—Lovastatin—atherosclerosis	0.000554	0.00816	CcSEcCtD
Levothyroxine—SLC7A5—cardiovascular system—atherosclerosis	0.000543	0.0438	CbGeAlD
Levothyroxine—Flushing—Niacin—atherosclerosis	0.000541	0.00798	CcSEcCtD
Levothyroxine—Angioedema—Lovastatin—atherosclerosis	0.00054	0.00796	CcSEcCtD
Levothyroxine—Flushing—Pravastatin—atherosclerosis	0.000533	0.00786	CcSEcCtD
Levothyroxine—Angioedema—Ezetimibe—atherosclerosis	0.00053	0.00781	CcSEcCtD
Levothyroxine—TTR—cardiovascular system—atherosclerosis	0.000529	0.0427	CbGeAlD
Levothyroxine—SLCO1C1—adipose tissue—atherosclerosis	0.000521	0.0421	CbGeAlD
Levothyroxine—Arrhythmia—Niacin—atherosclerosis	0.000521	0.00768	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000519	0.00765	CcSEcCtD
Levothyroxine—Tremor—Simvastatin—atherosclerosis	0.000518	0.00764	CcSEcCtD
Levothyroxine—Alopecia—Niacin—atherosclerosis	0.000515	0.0076	CcSEcCtD
Levothyroxine—Insomnia—Rosuvastatin—atherosclerosis	0.000515	0.00759	CcSEcCtD
Levothyroxine—Arrhythmia—Pravastatin—atherosclerosis	0.000513	0.00756	CcSEcCtD
Levothyroxine—Palpitations—Ezetimibe—atherosclerosis	0.000512	0.00755	CcSEcCtD
Levothyroxine—Alopecia—Pravastatin—atherosclerosis	0.000507	0.00748	CcSEcCtD
Levothyroxine—Angioedema—Simvastatin—atherosclerosis	0.000505	0.00745	CcSEcCtD
Levothyroxine—Arthralgia—Lovastatin—atherosclerosis	0.000503	0.00742	CcSEcCtD
Levothyroxine—Anxiety—Lovastatin—atherosclerosis	0.000502	0.00739	CcSEcCtD
Levothyroxine—Tension—Niacin—atherosclerosis	0.000498	0.00734	CcSEcCtD
Levothyroxine—Arthralgia—Ezetimibe—atherosclerosis	0.000494	0.00728	CcSEcCtD
Levothyroxine—Nervousness—Niacin—atherosclerosis	0.000493	0.00727	CcSEcCtD
Levothyroxine—Tension—Pravastatin—atherosclerosis	0.000491	0.00723	CcSEcCtD
Levothyroxine—Confusional state—Lovastatin—atherosclerosis	0.000486	0.00717	CcSEcCtD
Levothyroxine—Nervousness—Pravastatin—atherosclerosis	0.000486	0.00716	CcSEcCtD
Levothyroxine—SLC7A5—adipose tissue—atherosclerosis	0.000479	0.0386	CbGeAlD
Levothyroxine—Confusional state—Ezetimibe—atherosclerosis	0.000477	0.00703	CcSEcCtD
Levothyroxine—Arthralgia—Simvastatin—atherosclerosis	0.000471	0.00694	CcSEcCtD
Levothyroxine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000469	0.00692	CcSEcCtD
Levothyroxine—Anxiety—Simvastatin—atherosclerosis	0.000469	0.00692	CcSEcCtD
Levothyroxine—Tremor—Pravastatin—atherosclerosis	0.000468	0.0069	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000466	0.00686	CcSEcCtD
Levothyroxine—Angioedema—Niacin—atherosclerosis	0.000464	0.00684	CcSEcCtD
Levothyroxine—SLCO4C1—liver—atherosclerosis	0.000459	0.0371	CbGeAlD
Levothyroxine—Angioedema—Pravastatin—atherosclerosis	0.000457	0.00673	CcSEcCtD
Levothyroxine—Confusional state—Simvastatin—atherosclerosis	0.000455	0.00671	CcSEcCtD
Levothyroxine—Urticaria—Rosuvastatin—atherosclerosis	0.000452	0.00667	CcSEcCtD
Levothyroxine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00045	0.00663	CcSEcCtD
Levothyroxine—Palpitations—Niacin—atherosclerosis	0.000449	0.00661	CcSEcCtD
Levothyroxine—SLCO1B3—liver—atherosclerosis	0.000446	0.036	CbGeAlD
Levothyroxine—THRB—liver—atherosclerosis	0.00044	0.0355	CbGeAlD
Levothyroxine—THRA—liver—atherosclerosis	0.00044	0.0355	CbGeAlD
Levothyroxine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00044	0.00648	CcSEcCtD
Levothyroxine—Insomnia—Lovastatin—atherosclerosis	0.000436	0.00643	CcSEcCtD
Levothyroxine—Arthralgia—Niacin—atherosclerosis	0.000432	0.00637	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000431	0.00636	CcSEcCtD
Levothyroxine—Dyspnoea—Lovastatin—atherosclerosis	0.00043	0.00634	CcSEcCtD
Levothyroxine—Insomnia—Ezetimibe—atherosclerosis	0.000428	0.00631	CcSEcCtD
Levothyroxine—Arthralgia—Pravastatin—atherosclerosis	0.000426	0.00627	CcSEcCtD
Levothyroxine—Anxiety—Pravastatin—atherosclerosis	0.000424	0.00625	CcSEcCtD
Levothyroxine—Dyspnoea—Ezetimibe—atherosclerosis	0.000422	0.00622	CcSEcCtD
Levothyroxine—SLCO4A1—adipose tissue—atherosclerosis	0.000418	0.0337	CbGeAlD
Levothyroxine—Fatigue—Lovastatin—atherosclerosis	0.000416	0.00613	CcSEcCtD
Levothyroxine—Confusional state—Pravastatin—atherosclerosis	0.000411	0.00606	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000411	0.00606	CcSEcCtD
Levothyroxine—Asthenia—Rosuvastatin—atherosclerosis	0.000408	0.00602	CcSEcCtD
Levothyroxine—Insomnia—Simvastatin—atherosclerosis	0.000408	0.00602	CcSEcCtD
Levothyroxine—Fatigue—Ezetimibe—atherosclerosis	0.000408	0.00601	CcSEcCtD
Levothyroxine—Shock—Niacin—atherosclerosis	0.000408	0.00601	CcSEcCtD
Levothyroxine—Tachycardia—Niacin—atherosclerosis	0.000404	0.00596	CcSEcCtD
Levothyroxine—Pruritus—Rosuvastatin—atherosclerosis	0.000403	0.00594	CcSEcCtD
Levothyroxine—Dyspnoea—Simvastatin—atherosclerosis	0.000402	0.00593	CcSEcCtD
Levothyroxine—Hyperhidrosis—Niacin—atherosclerosis	0.000401	0.00591	CcSEcCtD
Levothyroxine—SLC16A2—liver—atherosclerosis	0.000398	0.0322	CbGeAlD
Levothyroxine—Feeling abnormal—Lovastatin—atherosclerosis	0.000398	0.00586	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000395	0.00582	CcSEcCtD
Levothyroxine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000394	0.00581	CcSEcCtD
Levothyroxine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00039	0.00575	CcSEcCtD
Levothyroxine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00039	0.00574	CcSEcCtD
Levothyroxine—Fatigue—Simvastatin—atherosclerosis	0.000389	0.00574	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000387	0.0057	CcSEcCtD
Levothyroxine—Urticaria—Lovastatin—atherosclerosis	0.000383	0.00565	CcSEcCtD
Levothyroxine—Abdominal pain—Lovastatin—atherosclerosis	0.000381	0.00562	CcSEcCtD
Levothyroxine—Body temperature increased—Lovastatin—atherosclerosis	0.000381	0.00562	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000378	0.00557	CcSEcCtD
Levothyroxine—Urticaria—Ezetimibe—atherosclerosis	0.000376	0.00554	CcSEcCtD
Levothyroxine—Insomnia—Niacin—atherosclerosis	0.000375	0.00552	CcSEcCtD
Levothyroxine—Abdominal pain—Ezetimibe—atherosclerosis	0.000374	0.00551	CcSEcCtD
Levothyroxine—Body temperature increased—Ezetimibe—atherosclerosis	0.000374	0.00551	CcSEcCtD
Levothyroxine—Feeling abnormal—Simvastatin—atherosclerosis	0.000372	0.00548	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000372	0.00548	CcSEcCtD
Levothyroxine—Dyspnoea—Niacin—atherosclerosis	0.000369	0.00545	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000369	0.00544	CcSEcCtD
Levothyroxine—Insomnia—Pravastatin—atherosclerosis	0.000369	0.00544	CcSEcCtD
Levothyroxine—Dyspnoea—Pravastatin—atherosclerosis	0.000364	0.00536	CcSEcCtD
Levothyroxine—Rash—Rosuvastatin—atherosclerosis	0.000359	0.00529	CcSEcCtD
Levothyroxine—Dermatitis—Rosuvastatin—atherosclerosis	0.000359	0.00529	CcSEcCtD
Levothyroxine—Urticaria—Simvastatin—atherosclerosis	0.000359	0.00528	CcSEcCtD
Levothyroxine—Abdominal pain—Simvastatin—atherosclerosis	0.000357	0.00526	CcSEcCtD
Levothyroxine—Body temperature increased—Simvastatin—atherosclerosis	0.000357	0.00526	CcSEcCtD
Levothyroxine—Headache—Rosuvastatin—atherosclerosis	0.000357	0.00526	CcSEcCtD
Levothyroxine—Fatigue—Pravastatin—atherosclerosis	0.000352	0.00519	CcSEcCtD
Levothyroxine—Asthenia—Lovastatin—atherosclerosis	0.000346	0.0051	CcSEcCtD
Levothyroxine—Pruritus—Lovastatin—atherosclerosis	0.000341	0.00503	CcSEcCtD
Levothyroxine—Asthenia—Ezetimibe—atherosclerosis	0.00034	0.00501	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Niacin—atherosclerosis	0.000339	0.005	CcSEcCtD
Levothyroxine—Nausea—Rosuvastatin—atherosclerosis	0.000338	0.00498	CcSEcCtD
Levothyroxine—Feeling abnormal—Pravastatin—atherosclerosis	0.000336	0.00496	CcSEcCtD
Levothyroxine—SLC7A5—liver—atherosclerosis	0.000336	0.0271	CbGeAlD
Levothyroxine—Pruritus—Ezetimibe—atherosclerosis	0.000335	0.00494	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000334	0.00492	CcSEcCtD
Levothyroxine—Diarrhoea—Lovastatin—atherosclerosis	0.00033	0.00487	CcSEcCtD
Levothyroxine—Urticaria—Niacin—atherosclerosis	0.000329	0.00485	CcSEcCtD
Levothyroxine—Abdominal pain—Niacin—atherosclerosis	0.000328	0.00483	CcSEcCtD
Levothyroxine—Body temperature increased—Niacin—atherosclerosis	0.000328	0.00483	CcSEcCtD
Levothyroxine—TTR—liver—atherosclerosis	0.000327	0.0264	CbGeAlD
Levothyroxine—Urticaria—Pravastatin—atherosclerosis	0.000324	0.00478	CcSEcCtD
Levothyroxine—Asthenia—Simvastatin—atherosclerosis	0.000324	0.00477	CcSEcCtD
Levothyroxine—Diarrhoea—Ezetimibe—atherosclerosis	0.000324	0.00477	CcSEcCtD
Levothyroxine—Body temperature increased—Pravastatin—atherosclerosis	0.000323	0.00475	CcSEcCtD
Levothyroxine—Abdominal pain—Pravastatin—atherosclerosis	0.000323	0.00475	CcSEcCtD
Levothyroxine—Pruritus—Simvastatin—atherosclerosis	0.000319	0.00471	CcSEcCtD
Levothyroxine—Diarrhoea—Simvastatin—atherosclerosis	0.000309	0.00455	CcSEcCtD
Levothyroxine—Vomiting—Lovastatin—atherosclerosis	0.000307	0.00452	CcSEcCtD
Levothyroxine—Rash—Lovastatin—atherosclerosis	0.000304	0.00448	CcSEcCtD
Levothyroxine—Dermatitis—Lovastatin—atherosclerosis	0.000304	0.00448	CcSEcCtD
Levothyroxine—Headache—Lovastatin—atherosclerosis	0.000302	0.00446	CcSEcCtD
Levothyroxine—Vomiting—Ezetimibe—atherosclerosis	0.000301	0.00444	CcSEcCtD
Levothyroxine—Rash—Ezetimibe—atherosclerosis	0.000298	0.0044	CcSEcCtD
Levothyroxine—Dermatitis—Ezetimibe—atherosclerosis	0.000298	0.00439	CcSEcCtD
Levothyroxine—Asthenia—Niacin—atherosclerosis	0.000297	0.00438	CcSEcCtD
Levothyroxine—Headache—Ezetimibe—atherosclerosis	0.000296	0.00437	CcSEcCtD
Levothyroxine—Pruritus—Niacin—atherosclerosis	0.000293	0.00432	CcSEcCtD
Levothyroxine—SLCO4A1—liver—atherosclerosis	0.000293	0.0237	CbGeAlD
Levothyroxine—Asthenia—Pravastatin—atherosclerosis	0.000293	0.00432	CcSEcCtD
Levothyroxine—Pruritus—Pravastatin—atherosclerosis	0.000289	0.00426	CcSEcCtD
Levothyroxine—Vomiting—Simvastatin—atherosclerosis	0.000287	0.00423	CcSEcCtD
Levothyroxine—Nausea—Lovastatin—atherosclerosis	0.000287	0.00422	CcSEcCtD
Levothyroxine—Rash—Simvastatin—atherosclerosis	0.000285	0.00419	CcSEcCtD
Levothyroxine—Dermatitis—Simvastatin—atherosclerosis	0.000284	0.00419	CcSEcCtD
Levothyroxine—Diarrhoea—Niacin—atherosclerosis	0.000284	0.00418	CcSEcCtD
Levothyroxine—Headache—Simvastatin—atherosclerosis	0.000283	0.00417	CcSEcCtD
Levothyroxine—Nausea—Ezetimibe—atherosclerosis	0.000281	0.00414	CcSEcCtD
Levothyroxine—Diarrhoea—Pravastatin—atherosclerosis	0.000279	0.00412	CcSEcCtD
Levothyroxine—Nausea—Simvastatin—atherosclerosis	0.000268	0.00395	CcSEcCtD
Levothyroxine—Vomiting—Niacin—atherosclerosis	0.000263	0.00388	CcSEcCtD
Levothyroxine—Rash—Niacin—atherosclerosis	0.000261	0.00385	CcSEcCtD
Levothyroxine—Dermatitis—Niacin—atherosclerosis	0.000261	0.00385	CcSEcCtD
Levothyroxine—Headache—Niacin—atherosclerosis	0.00026	0.00383	CcSEcCtD
Levothyroxine—Vomiting—Pravastatin—atherosclerosis	0.000259	0.00382	CcSEcCtD
Levothyroxine—SLCO1B1—liver—atherosclerosis	0.000258	0.0208	CbGeAlD
Levothyroxine—Rash—Pravastatin—atherosclerosis	0.000257	0.00379	CcSEcCtD
Levothyroxine—Dermatitis—Pravastatin—atherosclerosis	0.000257	0.00379	CcSEcCtD
Levothyroxine—Headache—Pravastatin—atherosclerosis	0.000256	0.00377	CcSEcCtD
Levothyroxine—ABCB1—blood vessel—atherosclerosis	0.000255	0.0206	CbGeAlD
Levothyroxine—Nausea—Niacin—atherosclerosis	0.000246	0.00363	CcSEcCtD
Levothyroxine—Nausea—Pravastatin—atherosclerosis	0.000242	0.00357	CcSEcCtD
Levothyroxine—Liotrix—ALB—atherosclerosis	0.000237	0.578	CrCbGaD
Levothyroxine—SLCO1A2—liver—atherosclerosis	0.00021	0.0169	CbGeAlD
Levothyroxine—ALB—liver—atherosclerosis	0.000209	0.0169	CbGeAlD
Levothyroxine—Liothyronine—ALB—atherosclerosis	0.000173	0.422	CrCbGaD
Levothyroxine—CYP2C8—liver—atherosclerosis	0.000147	0.0118	CbGeAlD
Levothyroxine—ABCB1—cardiovascular system—atherosclerosis	0.000114	0.00918	CbGeAlD
Levothyroxine—ABCB1—adipose tissue—atherosclerosis	0.0001	0.0081	CbGeAlD
Levothyroxine—CYP3A4—liver—atherosclerosis	9.93e-05	0.00802	CbGeAlD
Levothyroxine—ABCB1—liver—atherosclerosis	7.03e-05	0.00568	CbGeAlD
Levothyroxine—SLCO1A2—Metabolism—APOB—atherosclerosis	1.05e-05	0.000103	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MMP1—atherosclerosis	1.04e-05	0.000102	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCG5—atherosclerosis	1.04e-05	0.000102	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.04e-05	0.000102	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.04e-05	0.000102	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFB1—atherosclerosis	1.02e-05	0.0001	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTM1—atherosclerosis	1.02e-05	0.0001	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—LPA—atherosclerosis	1.01e-05	9.95e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—LPA—atherosclerosis	1.01e-05	9.89e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CAV1—atherosclerosis	1e-05	9.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1e-05	9.82e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—LPL—atherosclerosis	9.99e-06	9.81e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.99e-06	9.81e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—APOA1—atherosclerosis	9.98e-06	9.8e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	9.84e-06	9.67e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—BGN—atherosclerosis	9.81e-06	9.63e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP27A1—atherosclerosis	9.76e-06	9.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—BGN—atherosclerosis	9.75e-06	9.58e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GPX1—atherosclerosis	9.75e-06	9.57e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.74e-06	9.56e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOA5—atherosclerosis	9.71e-06	9.54e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	9.7e-06	9.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.68e-06	9.51e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOA5—atherosclerosis	9.65e-06	9.48e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CG—atherosclerosis	9.62e-06	9.45e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—atherosclerosis	9.57e-06	9.4e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	9.56e-06	9.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	9.55e-06	9.38e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—F2—atherosclerosis	9.52e-06	9.35e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CD36—atherosclerosis	9.49e-06	9.32e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.43e-06	9.26e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS2—atherosclerosis	9.4e-06	9.24e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.38e-06	9.21e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	9.35e-06	9.18e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—HMOX1—atherosclerosis	9.34e-06	9.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PLA2G1B—atherosclerosis	9.29e-06	9.13e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—atherosclerosis	9.28e-06	9.12e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	9.25e-06	9.08e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOA2—atherosclerosis	9.25e-06	9.08e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALOX15—atherosclerosis	9.25e-06	9.08e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	9.25e-06	9.08e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.24e-06	9.08e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.21e-06	9.04e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.19e-06	9.02e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.16e-06	8.99e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ABCG5—atherosclerosis	9.14e-06	8.97e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.13e-06	8.97e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CG—atherosclerosis	9.11e-06	8.95e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—INS—atherosclerosis	9.11e-06	8.94e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.1e-06	8.94e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.08e-06	8.92e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG8—atherosclerosis	9.07e-06	8.91e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LTA4H—atherosclerosis	9.07e-06	8.91e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALOX5—atherosclerosis	9.03e-06	8.87e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—MTHFR—atherosclerosis	9e-06	8.84e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALOX5—atherosclerosis	8.98e-06	8.82e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOB—atherosclerosis	8.95e-06	8.79e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	8.92e-06	8.76e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARA—atherosclerosis	8.83e-06	8.67e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LPA—atherosclerosis	8.82e-06	8.67e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTM1—atherosclerosis	8.7e-06	8.55e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—atherosclerosis	8.65e-06	8.5e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.64e-06	8.48e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NFKB1—atherosclerosis	8.56e-06	8.41e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AGT—atherosclerosis	8.55e-06	8.4e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—BGN—atherosclerosis	8.55e-06	8.39e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—LPL—atherosclerosis	8.54e-06	8.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOA5—atherosclerosis	8.46e-06	8.31e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK8—atherosclerosis	8.41e-06	8.26e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOE—atherosclerosis	8.38e-06	8.23e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—atherosclerosis	8.35e-06	8.2e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.34e-06	8.19e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IGF1—atherosclerosis	8.34e-06	8.19e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GPX1—atherosclerosis	8.34e-06	8.19e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CAV1—atherosclerosis	8.3e-06	8.15e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.29e-06	8.14e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOA1—atherosclerosis	8.28e-06	8.13e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	8.14e-06	8e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CD36—atherosclerosis	8.12e-06	7.97e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NAMPT—atherosclerosis	8.1e-06	7.95e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.07e-06	7.92e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NAMPT—atherosclerosis	8.05e-06	7.91e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.05e-06	7.91e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—LIPC—atherosclerosis	8.05e-06	7.9e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8e-06	7.86e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—LIPC—atherosclerosis	8e-06	7.86e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOC3—atherosclerosis	8e-06	7.85e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—NOS3—atherosclerosis	7.99e-06	7.84e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOC3—atherosclerosis	7.95e-06	7.81e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—LDLR—atherosclerosis	7.95e-06	7.81e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SERPINE1—atherosclerosis	7.92e-06	7.78e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—LDLR—atherosclerosis	7.9e-06	7.76e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALOX5—atherosclerosis	7.86e-06	7.72e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—atherosclerosis	7.77e-06	7.63e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CETP—atherosclerosis	7.76e-06	7.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CETP—atherosclerosis	7.72e-06	7.58e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MTHFR—atherosclerosis	7.69e-06	7.56e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—atherosclerosis	7.69e-06	7.56e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—atherosclerosis	7.67e-06	7.54e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.57e-06	7.43e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS3—atherosclerosis	7.56e-06	7.43e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	7.56e-06	7.42e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARA—atherosclerosis	7.55e-06	7.41e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SCARB1—atherosclerosis	7.43e-06	7.3e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SCARB1—atherosclerosis	7.39e-06	7.26e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—atherosclerosis	7.35e-06	7.22e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AGT—atherosclerosis	7.31e-06	7.18e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—atherosclerosis	7.3e-06	7.17e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—atherosclerosis	7.29e-06	7.17e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.24e-06	7.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG1—atherosclerosis	7.17e-06	7.05e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOE—atherosclerosis	7.16e-06	7.03e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—INS—atherosclerosis	7.15e-06	7.03e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—atherosclerosis	7.13e-06	7e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CAV1—atherosclerosis	7.1e-06	6.97e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOA1—atherosclerosis	7.08e-06	6.95e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—atherosclerosis	7.08e-06	6.95e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NAMPT—atherosclerosis	7.05e-06	6.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HMGCR—atherosclerosis	7.02e-06	6.9e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LIPC—atherosclerosis	7.01e-06	6.88e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HMGCR—atherosclerosis	6.98e-06	6.86e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOC3—atherosclerosis	6.97e-06	6.84e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LDLR—atherosclerosis	6.92e-06	6.8e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CETP—atherosclerosis	6.76e-06	6.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FABP4—atherosclerosis	6.74e-06	6.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LCAT—atherosclerosis	6.74e-06	6.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	6.74e-06	6.62e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.64e-06	6.52e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOA4—atherosclerosis	6.62e-06	6.5e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—atherosclerosis	6.56e-06	6.44e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.5e-06	6.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SCARB1—atherosclerosis	6.48e-06	6.36e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	6.46e-06	6.35e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.33e-06	6.22e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.3e-06	6.18e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NOS3—atherosclerosis	6.27e-06	6.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCA1—atherosclerosis	6.26e-06	6.15e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—atherosclerosis	6.24e-06	6.13e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCA1—atherosclerosis	6.22e-06	6.11e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—INS—atherosclerosis	6.12e-06	6.01e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HMGCR—atherosclerosis	6.12e-06	6.01e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.01e-06	5.9e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6e-06	5.89e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—atherosclerosis	5.74e-06	5.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOA2—atherosclerosis	5.7e-06	5.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.7e-06	5.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.7e-06	5.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.7e-06	5.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.63e-06	5.53e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—atherosclerosis	5.61e-06	5.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ABCA1—atherosclerosis	5.45e-06	5.35e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—atherosclerosis	5.45e-06	5.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LPA—atherosclerosis	5.44e-06	5.34e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—atherosclerosis	5.37e-06	5.28e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HMOX1—atherosclerosis	5.37e-06	5.27e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NOS3—atherosclerosis	5.37e-06	5.27e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HMOX1—atherosclerosis	5.34e-06	5.24e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BGN—atherosclerosis	5.26e-06	5.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOA5—atherosclerosis	5.21e-06	5.12e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—atherosclerosis	5.15e-06	5.06e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOB—atherosclerosis	5.14e-06	5.05e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOB—atherosclerosis	5.11e-06	5.02e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.02e-06	4.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—atherosclerosis	5e-06	4.91e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—atherosclerosis	5e-06	4.91e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—atherosclerosis	4.97e-06	4.89e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—atherosclerosis	4.96e-06	4.87e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—LPL—atherosclerosis	4.91e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—atherosclerosis	4.91e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—LPL—atherosclerosis	4.88e-06	4.79e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.85e-06	4.76e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GPX1—atherosclerosis	4.79e-06	4.7e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPX1—atherosclerosis	4.76e-06	4.68e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.68e-06	4.59e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CD36—atherosclerosis	4.66e-06	4.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CD36—atherosclerosis	4.64e-06	4.56e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOB—atherosclerosis	4.48e-06	4.4e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.42e-06	4.34e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—atherosclerosis	4.4e-06	4.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.36e-06	4.28e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.35e-06	4.27e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARA—atherosclerosis	4.34e-06	4.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LIPC—atherosclerosis	4.32e-06	4.24e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARA—atherosclerosis	4.31e-06	4.24e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOC3—atherosclerosis	4.29e-06	4.22e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LPL—atherosclerosis	4.28e-06	4.2e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LDLR—atherosclerosis	4.27e-06	4.19e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AGT—atherosclerosis	4.2e-06	4.13e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AGT—atherosclerosis	4.18e-06	4.1e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPX1—atherosclerosis	4.17e-06	4.1e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CETP—atherosclerosis	4.17e-06	4.09e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOE—atherosclerosis	4.12e-06	4.04e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOE—atherosclerosis	4.09e-06	4.02e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAV1—atherosclerosis	4.08e-06	4.01e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOA1—atherosclerosis	4.07e-06	4e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CD36—atherosclerosis	4.06e-06	3.99e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAV1—atherosclerosis	4.05e-06	3.98e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOA1—atherosclerosis	4.05e-06	3.97e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.99e-06	3.92e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.85e-06	3.78e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARA—atherosclerosis	3.78e-06	3.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.77e-06	3.7e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.71e-06	3.65e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—atherosclerosis	3.69e-06	3.63e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—atherosclerosis	3.67e-06	3.61e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AGT—atherosclerosis	3.66e-06	3.59e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOE—atherosclerosis	3.59e-06	3.52e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.58e-06	3.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—atherosclerosis	3.56e-06	3.5e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAV1—atherosclerosis	3.55e-06	3.49e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOA1—atherosclerosis	3.54e-06	3.48e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—INS—atherosclerosis	3.52e-06	3.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—INS—atherosclerosis	3.5e-06	3.43e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—atherosclerosis	3.48e-06	3.41e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.36e-06	3.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.24e-06	3.18e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—atherosclerosis	3.22e-06	3.17e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—atherosclerosis	3.12e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NOS3—atherosclerosis	3.08e-06	3.03e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NOS3—atherosclerosis	3.07e-06	3.01e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—INS—atherosclerosis	3.06e-06	3.01e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—atherosclerosis	2.88e-06	2.83e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.88e-06	2.83e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.82e-06	2.77e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—atherosclerosis	2.81e-06	2.76e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—atherosclerosis	2.8e-06	2.75e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOB—atherosclerosis	2.76e-06	2.71e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NOS3—atherosclerosis	2.69e-06	2.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.68e-06	2.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LPL—atherosclerosis	2.64e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.57e-06	2.53e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CD36—atherosclerosis	2.5e-06	2.46e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—atherosclerosis	2.47e-06	2.42e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.46e-06	2.41e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.37e-06	2.33e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.33e-06	2.29e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AGT—atherosclerosis	2.25e-06	2.21e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOE—atherosclerosis	2.21e-06	2.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.19e-06	2.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.18e-06	2.14e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.99e-06	1.96e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.92e-06	1.89e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—INS—atherosclerosis	1.89e-06	1.85e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—atherosclerosis	1.73e-06	1.7e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.65e-06	1.63e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.51e-06	1.49e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.42e-06	1.39e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—atherosclerosis	1.41e-06	1.38e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—atherosclerosis	1.23e-06	1.21e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—atherosclerosis	7.61e-07	7.47e-06	CbGpPWpGaD
